IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Apogee Therapeutics Inc

CUSIP: 03770N901 | 4 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile